Russell Investments Group Ltd. Boosts Position in DocGo Inc. (NASDAQ:DCGO)

Russell Investments Group Ltd. grew its holdings in DocGo Inc. (NASDAQ:DCGO) by 8.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 144,116 shares of the company’s stock after acquiring an additional 10,706 shares during the period. Russell Investments Group Ltd. owned about 0.14% of DocGo worth $611,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. WCM Investment Management LLC boosted its holdings in DocGo by 64.2% in the fourth quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company’s stock valued at $18,637,000 after purchasing an additional 1,687,100 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of DocGo by 490.3% in the 4th quarter. American Century Companies Inc. now owns 452,254 shares of the company’s stock valued at $1,918,000 after buying an additional 375,637 shares during the period. Harbor Capital Advisors Inc. boosted its stake in shares of DocGo by 37.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company’s stock worth $5,647,000 after buying an additional 363,391 shares during the last quarter. First Eagle Investment Management LLC acquired a new stake in DocGo during the fourth quarter worth about $1,116,000. Finally, JPMorgan Chase & Co. raised its position in DocGo by 199.3% during the fourth quarter. JPMorgan Chase & Co. now owns 328,796 shares of the company’s stock valued at $1,394,000 after acquiring an additional 218,941 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Price Performance

Shares of NASDAQ:DCGO opened at $2.11 on Wednesday. The business’s 50 day moving average price is $3.10 and its 200-day moving average price is $3.78. DocGo Inc. has a 1 year low of $2.02 and a 1 year high of $5.68. The firm has a market capitalization of $215.18 million, a price-to-earnings ratio of 7.54, a price-to-earnings-growth ratio of 14.16 and a beta of 1.12.

Analyst Upgrades and Downgrades

DCGO has been the topic of several recent research reports. Needham & Company LLC restated a “buy” rating and issued a $4.00 price objective on shares of DocGo in a research report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a “buy” rating to a “hold” rating and lowered their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Stifel Nicolaus dropped their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating on the stock in a research report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $4.89.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.